AstraZeneca PLC is 78.7x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($286.27 B vs $3.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACAD | AZN |
|---|---|---|
| Market cap | $3.64 B | $286.27 B |
| US-listed rank | #1650 | #45 |
| Revenue (latest FY) | $1.07B | - |
| Net income (latest FY) | $391.00M | - |
| Net margin | 36.5% | - |
| P/E (trailing FY) | 9.3 | - |
| SEC filings | 1,357 | 1,004 |
AstraZeneca PLC is 78.7x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($286.27 B vs $3.64 B).
Full pages: ACADIA PHARMACEUTICALS INC and AstraZeneca PLC, or browse the full rankings.